A Study of Galcanezumab (LY2951742) in Participants With Episodic Migraine

PHASE3CompletedINTERVENTIONAL
Enrollment

520

Participants

Timeline

Start Date

July 30, 2019

Primary Completion Date

July 27, 2021

Study Completion Date

March 11, 2022

Conditions
Episodic Migraine
Interventions
DRUG

Galcanezumab

Administered SC

DRUG

Placebo

Administered SC

Trial Locations (40)

20000

Shanghai East Hospital, Shanghai

20040

HuaShan Hospital Affiliated To Fudan University, Shanghai

100053

Xuanwu Hospital-Capital Medical University, Beijing

100853

Chinese PLA General Hospital, Beijing

110002

Gobind Ballabh Pant Hospital, New Delhi

110029

All India Institute of Medical Sciences, New Delhi

110060

Sir Ganga Ram Hospital, New Delhi

119991

First Moscow State Medical University n.a. Sechenov, Moscow

121467

University Headache Clinic, Moscow

122001

Artemis Hospital, Gurgaon

130041

No.2 Hospital Affiliated to Jilin University, Changchun

197022

Academician I.P. Pavlov First St-Petersburg State Medical University, Saint Petersburg

200032

Zhongshan Hospital, Fudan University, Shanghai

210029

Jiangsu Province Hospital, Nanjing

212000

Affiliated Hospital of Jiangsu University, Zhenjiang

215000

The First Affliated Hospital of Soochow University, Suzhou

250013

Jinan Central Hospital, Jinan

276826

People's hospital of Rizhao, Rizhao

300052

Tianjin Medical University General Hospital, Tianjin

300350

Tianjin Huanhu Hospital, Tianjin

310013

Zhejiang Hospital, Hangzhou

337000

Pingxiang People's Hospital, Pingxiang

382428

Apollo Hospitals International Ltd., Ahmedabad

400016

The First Affiliated Hospital Chongqing Medical University, Chongqing

410008

Xiangya Hospital, Central South University, Changsha

411004

Deenanath Mangeshkar Hospital & Research Centre, Pune

422001

HCG Manavata Cancer Centre, Nashik

430022

Wuhan Union Hospital, Wuhan

430030

Tongji Hosp Tongji Med Col Huazhong Univ of Sci & Tech, Wuhan

440012

Getwell Hospital & Research Institute, Nagpur

450052

The First Affiliated Hospital of Zhengzhou Universtiy, Zhengzhou

452008

CHL - Apollo Hospital, Indore

510180

Guangzhou First People's Hospital, Guangzhou

550004

The Affiliated Hospital of Guiyang Medical College, Guiyang

575003

Mangala Hospitals & Mangala Kidney Foundation, Mangalore

603137

"OOO Medis", Nizhny Novgorod

610041

West China Hospital Sichuan University, Chengdu

650032

First Affiliated Hospital of Kunming Medical University, Kunming

710061

First Affiliated Hospital of Xi'an Jiaotong University, Xi'an

014040

Bao Tou Central Hospital, Baotou

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT03963232 - A Study of Galcanezumab (LY2951742) in Participants With Episodic Migraine | Biotech Hunter | Biotech Hunter